Bisbenzoxazole Derivatives: Design, Synthesis, in Vitro Antimicrobial, Antiproliferative Activity, and Molecular Docking Studies
dc.authorid | HAJ ERSAN, RONAK/0000-0001-6651-5910 | |
dc.authorid | Duran, Nizami/0000-0002-2766-3491 | |
dc.authorid | Dogen, Aylin/0000-0002-0388-306X | |
dc.contributor.author | Ersan, Ronak Haj | |
dc.contributor.author | Alagoz, Mehmet Abdullah | |
dc.contributor.author | Dogen, Aylin | |
dc.contributor.author | Duran, Nizami | |
dc.contributor.author | Burmaoglu, Serdar | |
dc.contributor.author | Algul, Oztekin | |
dc.date.accessioned | 2024-09-18T20:04:32Z | |
dc.date.available | 2024-09-18T20:04:32Z | |
dc.date.issued | 2022 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Four series of bisbenzoxazole derivatives were designed, synthesized, and screened for antiproliferative and antimicrobial activities. Generally, all synthesized bisbenzoxazoles (9-24) displayed significant antiproliferative activity; these effects were shown to be related to oxazole rings and substituents in bisbenzoxazole compounds. Especially, the series bearing chloro-substituent (9-12) exhibited better antiproliferative activity with higher selectivity than the other series (13-24); the IC50 values were observed in the range of 0.045-0.342 mu M. Interestingly, only the compound with a nitro substituent (22) showed maximum potency with an IC50 value of 0.011 mu M, which is two-fold more active than the standard drug methotrexate, with moderate selectivity. The compounds bearing fluoro-substituent (14-16) were found to exhibit potent antibacterial activity against the Gram-positive Enterococcus faecalis, with a MIC value of 62.5 mu g/mL, and moderate activity against Gram-negative bacteria and fungi. Only the compound 23 showed potent activity against Escherichia coli, with a MIC value of 62.5 mu g/mL. In order to better evaluate the activity results, crystal structures of five different proteins Human Anaplastic Lymphoma Kinase (PDB ID: 2XP2), CYP2C8dH complexed (PDB ID: 2NNI), factor-human kinase-beta enzyme IKK-beta enzyme (PDB ID: 4KIK), a tubulin heterodimer complex containing alpha and beta sub-units (PDB ID: 1Z2B) and penicillin-binding protein 4 (PBP4) from Enterococcus faecalis (PDB ID: 6MKI) were used in the docking study to examine antiproliferative and antimicrobial activity. Finally, an ADMET screening test was applied to determine the drug-like, toxicological, and optimum physicochemical properties for all of the synthesized compounds. The strategy applied in this research may act as a perspective for the rational design of potential anticancer drugs. | en_US |
dc.description.sponsorship | Scientific and Technological Research Council of Turkey (TUBITAK) [115S190]; Mersin University [BAP-SBE-2018-1-TP3-2911] | en_US |
dc.description.sponsorship | We thank the Scientific and Technological Research Council of Turkey (TUBITAK Grant Number: 115S190) and Mersin University for their financial support (BAP-SBE-2018-1-TP3-2911). | en_US |
dc.identifier.doi | 10.1080/10406638.2020.1852589 | |
dc.identifier.endpage | 3123 | en_US |
dc.identifier.issn | 1040-6638 | |
dc.identifier.issn | 1563-5333 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.scopus | 2-s2.0-85096821382 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 3103 | en_US |
dc.identifier.uri | https://doi.org/10.1080/10406638.2020.1852589 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/8229 | |
dc.identifier.volume | 42 | en_US |
dc.identifier.wos | WOS:000594055500001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Polycyclic Aromatic Compounds | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Bisbenzoxazole | en_US |
dc.subject | synthesis | en_US |
dc.subject | antimicrobial activity | en_US |
dc.subject | antiproliferative activity | en_US |
dc.subject | molecular docking | en_US |
dc.title | Bisbenzoxazole Derivatives: Design, Synthesis, in Vitro Antimicrobial, Antiproliferative Activity, and Molecular Docking Studies | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1